OncoResponse Mines PD-1 Therapy “Elite Responders” For IO Breakthroughs

 
• By Joseph Haas

Emerging Company Profile: Harvesting blood and tissue samples from patients treated with PD-1 immunotherapy, OncoResponse is developing antibodies it believes can transform cold solid tumors into hot.

Tumor microenvironment, OncoResponse profile
OncoResponse's technology focuses on the tumor microenvironment and turning "cold" tumors "hot" • Source: Alamy

More from Emerging Company Profiles

More from Start-Ups & SMEs